|
ERYTHROMYCIN INCREASES PLASMA CONCENTRATION OF THE DRUG DUE TO REDUCED CLEARANCE
|
LINCOMYCIN & RELATED DRUGS INCREASE ITS PLASMA CONCENTRATION
|
PHENYTOIN ENHANCES THE DRUG METABOLISM HENCE DECREASED SERUM LEVELS HAVE BEEN OBSERVED
|
OXYTETRACYCLINE INCREASES PLASMA CONCENTRATION OF THE DRUG
|
CLINDAMYCIN INCREASES PLASMA CONCENTRATION OF THE DRUG
|
ANTICOAGULANTS MAY INCREASE PLASMA CONCENTRATION OF THE DRUG
|
ANTICOAGULANTS MAY INCREASE PLASMA CONCENTRATION OF THE DRUG
|
ANTICOAGULANTS MAY INCREASE PLASMA CONCENTRATION OF THE DRUG
|
ANTICOAGULANTS MAY INCREASE PLASMA CONCENTRATION OF THE DRUG
|
ANTICOAGULANTS MAY INCREASE PLASMA CONCENTRATION OF THE DRUG
|
ANTICOAGULANTS MAY INCREASE PLASMA CONCENTRATION OF THE DRUG
|
ANTICOAGULANTS MAY INCREASE PLASMA CONCENTRATION OF THE DRUG
|
ACEBROPHYLLINE CAN POTENTIATE DIURETIC EFFECT
|
CO-ADMINISTRATION CAN CAUSE TACHYCARDIA
|
BARBITURATES INCREASE ITS METABOLISM LEADING TO REDUCED EFFICACY
|
BARBITURATES INCREASE ITS METABOLISM LEADING TO REDUCED EFFICACY
|
BARBITURATES INCREASE ITS METABOLISM LEADING TO REDUCED EFFICACY
|
BARBITURATES INCREASE ITS METABOLISM LEADING TO REDUCED EFFICACY
|
BARBITURATES INCREASE ITS METABOLISM LEADING TO REDUCED EFFICACY
|
BARBITURATES INCREASE ITS METABOLISM LEADING TO REDUCED EFFICACY
|
BARBITURATES INCREASE ITS METABOLISM LEADING TO REDUCED EFFICACY
|
BARBITURATES INCREASE ITS METABOLISM LEADING TO REDUCED EFFICACY
|
BARBITURATES INCREASE ITS METABOLISM LEADING TO REDUCED EFFICACY
|
BARBITURATES INCREASE ITS METABOLISM LEADING TO REDUCED EFFICACY
|
ALLOPURINOL REDUCES RENAL CLEARANCE OF THE DRUG SO THE DRUG DOSE SHOULD BE REDUCED TO 1/3 OR 1/4
|
CIMETIDINE DECREASES RENAL CLEARANCE OF THE DRUG LEADING TO INCREASED PLASMA LEVELS
|
QUINOLONES MAY INCREASE THE PLASMA LEVELS OF THE DRUG
|
QUINOLONES MAY INCREASE THE PLASMA LEVELS OF THE DRUG
|
QUINOLONES MAY INCREASE THE PLASMA LEVELS OF THE DRUG
|
QUINOLONES MAY INCREASE THE PLASMA LEVELS OF THE DRUG
|
QUINOLONES MAY INCREASE THE PLASMA LEVELS OF THE DRUG
|
QUINOLONES MAY INCREASE THE PLASMA LEVELS OF THE DRUG
|
QUINOLONES MAY INCREASE THE PLASMA LEVELS OF THE DRUG
|
QUINOLONES MAY INCREASE THE PLASMA LEVELS OF THE DRUG
|
QUINOLONES MAY INCREASE THE PLASMA LEVELS OF THE DRUG
|
QUINOLONES MAY INCREASE THE PLASMA LEVELS OF THE DRUG
|
QUINOLONES MAY INCREASE THE PLASMA LEVELS OF THE DRUG
|
QUINOLONES MAY INCREASE THE PLASMA LEVELS OF THE DRUG
|
QUINOLONES MAY INCREASE THE PLASMA LEVELS OF THE DRUG
|
QUINOLONES MAY INCREASE THE PLASMA LEVELS OF THE DRUG
|
QUINOLONES MAY INCREASE THE PLASMA LEVELS OF THE DRUG
|
QUINOLONES MAY INCREASE THE PLASMA LEVELS OF THE DRUG
|
CONCOMITANT USE SHOULD BE AVOIDED
|
CONCOMITANT USE SHOULD BE AVOIDED
|
CONCOMITANT USE SHOULD BE AVOIDED
|
CONCOMITANT USE SHOULD BE AVOIDED
|
CONCOMITANT USE SHOULD BE AVOIDED
|
CONCOMITANT USE SHOULD BE AVOIDED
|
CONCOMITANT USE SHOULD BE AVOIDED
|
CONCOMITANT USE SHOULD BE AVOIDED
|
CONCOMITANT USE SHOULD BE AVOIDED
|
CONCOMITANT USE SHOULD BE AVOIDED
|
CONCOMITANT USE SHOULD BE AVOIDED
|
CONCOMITANT USE SHOULD BE AVOIDED
|
CONCOMITANT USE SHOULD BE AVOIDED
|
CONCOMITANT USE SHOULD BE AVOIDED
|
CONCOMITANT USE SHOULD BE AVOIDED
|
CEPHALEXIN INCREASES PLASMA CONCENTRATION OF THE DRUG
|
CEPHALEXIN INCREASES PLASMA CONCENTRATION OF THE DRUG
|